PerCP/Cyanine5.5 Rat IgG2c, κ Isotype Ctrl
The isotype of RTK4174 immunoglobulin is rat IgG2c, κ. This antibody was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.
PRODUCT DETAILS
Clone: RTK4174
Antibody Type: Monoclonal
Reactivity: None
Format: PerCP-Cyanine5.5
Host: Rat
Isotype: IgG2c, κ
Applications: FC - Quality tested ICFC - Verified
Regulatory Status: RUO
Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.
Original: $103.00
-70%$103.00
$30.90PerCP/Cyanine5.5 Rat IgG2c, κ Isotype Ctrl
The isotype of RTK4174 immunoglobulin is rat IgG2c, κ. This antibody was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.
PRODUCT DETAILS
Clone: RTK4174
Antibody Type: Monoclonal
Reactivity: None
Format: PerCP-Cyanine5.5
Host: Rat
Isotype: IgG2c, κ
Applications: FC - Quality tested ICFC - Verified
Regulatory Status: RUO
Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
The isotype of RTK4174 immunoglobulin is rat IgG2c, κ. This antibody was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.
PRODUCT DETAILS
Clone: RTK4174
Antibody Type: Monoclonal
Reactivity: None
Format: PerCP-Cyanine5.5
Host: Rat
Isotype: IgG2c, κ
Applications: FC - Quality tested ICFC - Verified
Regulatory Status: RUO
Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.
